Coherus BioSciences Inc. (CHRS)

NASDAQ: CHRS · Real-Time Price · USD

1.03

0.00 (0.00%)

At close: May 01, 2025, 3:59 PM

1.05

1.45%

Pre-market: May 02, 2025, 08:29 AM EDT

Coherus BioSciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	266.96M	257.24M	211.04M	326.55M	475.82M	356.07M	1.56M	1.56M	190.11M
Cost of Revenue	117.55M	162.78M	70.08M	57.59M	37.67M	17.08M	3.23M	160.53M	254.44M
Gross Profit	149.41M	94.46M	140.96M	268.96M	438.16M	338.99M	-1.68M	-158.97M	-64.33M
Operating Income	-111.67M	-203.2M	-256.88M	-263.86M	156.32M	107.77M	-204.42M	-232.14M	-115.93M
Interest Income	n/a	n/a	30.57M	21.56M	20.57M	16M	n/a	n/a	n/a
Pretax Income	28.51M	-238.27M	-291.75M	-287.1M	135.71M	92.78M	-209.41M	-238.29M	-127.79M
Net Income	28.51M	-237.89M	-326.63M	-306.32M	132.24M	89.83M	-209.34M	-238.17M	-127.34M
Selling & General & Admin	167.74M	185.62M	198.48M	169.71M	139.08M	137.04M	94.18M	71.3M	51.6M
Research & Development	93.34M	109.44M	199.36M	363.11M	142.76M	94.19M	110.24M	162.39M	254.44M
Other Expenses	n/a	n/a	3.82M	-283K	554K	2.61M	4.69M	3.4M	-3.88M
Operating Expenses	261.07M	301.45M	397.84M	532.82M	281.84M	231.22M	204.42M	233.69M	306.04M
Interest Expense	27.16M	40.54M	32.47M	22.96M	21.17M	17.6M	9.68M	9.55M	7.98M
Selling & Marketing Expenses	n/a	n/a	10.5M	8.7M	3.8M	4.5M	2.8M	n/a	n/a
Cost & Expenses	378.63M	460.44M	467.92M	590.41M	319.5M	248.3M	204.42M	233.69M	306.04M
Income Tax Expense	n/a	-380K	34.87M	19.22M	3.46M	2.94M	4.69M	9.44M	656K
Shares Outstanding (Basic)	114.55M	94.16M	77.63M	75.45M	71.41M	69.68M	65.01M	53.13M	41.91M
Shares Outstanding (Diluted)	114.83M	94.16M	77.63M	75.45M	83.49M	73.19M	65.03M	53.13M	41.91M
EPS (Basic)	0.25	-2.53	-4.21	-4.06	1.85	1.29	-3.22	-4.48	-3.04
EPS (Diluted)	0.25	-2.53	-4.21	-4.06	1.62	1.23	-3.22	-4.48	-3.04
EBITDA	60.94M	-193.94M	-255.58M	-260.69M	161.84M	111.03M	-204.42M	-225.34M	-116.81M
EBIT	55.66M	-197.73M	-259.28M	-264.14M	156.87M	107.77M	-200.56M	-228.73M	-119.81M
Depreciation & Amortization	5.28M	3.79M	3.7M	5.66M	4.97M	3.26M	3.23M	3.4M	3M